Table 1.
Population characteristics of the entire cohort, hypertensive emergencies and hypertensive urgencies
| All patients (N = 670) | Hypertensive emergencies (n = 385) | Hypertensive urgencies (n = 285) | P value | |
|---|---|---|---|---|
| Age, mean (SD) | 73.0 ± 16 | 76.6 ± 18 | 67.2 ± 15 | .001 |
| Women, No. (%) | 371 (55.0) | 205 (53.2) | 166 (58.2) | .198 |
| SBP, mean (SD) | 197.8 ± 22.5 | 197.2 ± 21 | 199.0 ± 24 | .335 |
| DBP, mean (SD) | 98.91 ± 19 | 99.3 ± 20 | 98.0 ± 18 | .364 |
| SBP post treatment, mean (SD) | 173.8 ± 25 | 174.0 ± 24 | 172.4 ± 26 | .111 |
| DBP post treatment, mean (SD) | 88.2 ± 20.25 | 88.8 ± 22.2 | 87.7 ± 18 | .093 |
| Preexisting hypertension, No. (%) | 530 (79.1) | 295 (76.6) | 235 (82.4) | .468 |
| Hypertension drug, No. (%) | 470 (70.1) | 278 (72.2) | 192 (67.3) | .121 |
| Calcium antagonists | 191 (40.6, n = 470) | 110 (39.5, n = 278) | 81 (42.2, n = 192) | |
| Diuretics | 185 (39.3) | 131 (47.1) | 54 (28.1) | |
| β‐Blockers | 173 (36.8) | 119 (42.8) | 54 (28.1) | |
| Angiotensin receptor blockers | 150 (31.9) | 82 (29.5) | 68 (35.4) | |
| ACEIs | 130 (27.7) | 74 (26.6) | 56 (29.2) | |
| Others | 56 (11.9) | 32 (11.5) | 24 (12.5) | |
| Monotherapy, No. (%) | 199 (29.7) | 105 (27.2) | 94 (32.9) | .120 |
| Two‐drug combination, No. (%) | 161 (24.0) | 101 (26.2) | 60 (21.0) | .112 |
| ≥3‐drug combination, No. (%) | 110 (16.4) | 72 (18.7) | 38 (13.3) | .062 |
Abbreviations: ACEI, angiotensin‐converting enzyme inhibitor; DBP, diastolic blood pressure; SBP, systolic blood pressure; SD, standard deviation. Boldface indicates significance at P < .05.